Search For "bharat biotech covaxin"
"Safety is primary focus for all our vaccines": Covaxin-developer Bharat B
Updated : 1 year, 10 months ago IST
Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first."
Read More
Bharat Biotech, institute Sydney ID partner to combat infectious diseases
Updated : 2 years, 3 months ago IST
Bharat Biotech is a world-leading vaccine and biotherapeutics manufacturer. During the Covid pandemic, it made the vaccine Covaxin, which was administered by millions across the globe
Read More
Japan approves COVAXIN booster dose for travellers: Bharat Biotech
Updated : 3 years, 7 months ago IST
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 3 years, 10 months ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More
COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 9 (ANI): Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for
Read More
Covaxin supply suspension by WHO not to impact travel by people: MEA
Updated : 3 years, 11 months ago IST
New Delhi [India], April 8 (ANI): World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said o
Read More
WHO suspension for Covaxin supply only for UN agencies: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], April 4 (ANI): The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.
Read More
Bharat Biotech temporarily slows down COVAXIN production for facility opti
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
Read More
Covaxin maker Bharat Biotech Chairman Krishna Ella, wife Suchitra Ella to
Updated : 4 years, 1 month ago IST
New Delhi [India], January 25 (ANI): Bharat Biotech Chairman Krishna Ella and co-founder Suchitra Ella will be conferred with Padma Bhushan on the 73rd Republic Day.
Read More
COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bhara
Updated : 4 years, 1 month ago IST
New Delhi [India], January 14 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a universal vaccine for adults and children.
Read More
COVID-19: Bharat Biotech urges healthcare workers to ensure administration
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], January 8 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country and urged healthcare workers t
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More